Imbalances in bone formation and resorption cause
osteoporosis. Mounting evidence supports that
brain-derived neurotrophic factor (
BDNF) implicates in this process.
7,8-Dihydroxyflavone (7,8-DHF), a plant-derived small molecular TrkB agonist, mimics the functions of
BDNF. We show that both
BDNF and 7,8-DHF promoted the proliferation, osteogenic differentiation, and mineralization of MC3T3-E1 cells. These effects might be attributed to the activation of the Wnt/β-
catenin signaling pathway as the expression of
cyclin D1, phosphorylated-
glycogen synthase kinase-3β (p-GSK3β), β-
catenin, Runx2, Osterix, and
osteoprotegerin (OPG) was all significantly up-regulated. Knockdown of β-
catenin restrained the up-regulation of Runx2 and Osterix stimulated by 7,8-DHF. In particular, blocking TrkB by its specific inhibitor
K252a suppressed 7,8-DHF-induced osteoblastic proliferation, differentiation, and expression of osteoblastogenic genes. Moreover,
BDNF and 7,8-DHF repressed osteoclastic differentiation of RAW264.7 cells. The
transcription factor c-fos and osteoclastic genes such as
tartrate-resistant acid phosphatase (TRAP), matrix metalloprotein-9 (MMP-9), Adamts5 were inhibited by 7,8-DHF. More importantly, 7,8-DHF attenuated bone loss, improved trabecular microarchitecture, tibial biomechanical properties, and bone biochemical indexes in an
ovariectomy (OVX) rat model. The current work highlights the dual regulatory effects that 7,8-DHF exerts on bone remodeling.